Stanford University
Showing 1,301-1,400 of 1,477 Results
-
Imee Diego DuBose
Director, Alumni Education, Alumni Education Admin
Current Role at StanfordDirector, Alumni Education
-
Alfredo Dubra, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsOur lab seeks to help the early diagnosing and monitoring progression of ocular, vascular, neurodegenerative and systemic diseases through novel non-invasive optical ophthalmic imaging. We pursue this goal through a multidisciplinary approach that integrates optics, computer science, vision science, electrical engineering and other engineering disciplines.
-
Piotr Dubrowski
Clinical Instructor, Radiation Oncology - Radiation Physics
BioPiotr Dubrowski is a Canadian trained and board-certified Therapy Medical Physicist. Throughout his career Piotr has had the opportunity to bring several new Cancer Clinics operational from the ground up, where he was able to hone a broad, systems-approach to Radiation Oncology. He was recently promoted to Associate Quality Director of Physics responsible for improving patient safety and workflow/technology improvements across a wide cancer care network. Piotr’s research interests focus mainly on improving the treatment planning process and increasing clinic safety through software development and hardware 3D-print prototyping. Additionally, Piotr has sought out opportunities to give back to the Global community with participation in the Stanford Global Radiation Oncology Outreach efforts expanding education and access to care in Tanzania and Kenya and throughout the developing world via online Radiation Therapy courses.
-
John Duchi
Associate Professor of Statistics, of Electrical Engineering and, by courtesy, of Computer Science
Current Research and Scholarly InterestsMy work spans statistical learning, optimization, information theory, and computation, with a few driving goals: 1. To discover statistical learning procedures that optimally trade between real-world resources while maintaining statistical efficiency. 2. To build efficient large-scale optimization methods that move beyond bespoke solutions to methods that robustly work. 3. To develop tools to assess and guarantee the validity of---and confidence we should have in---machine-learned systems.
-
ashley dudarenok
Affiliate, Graduate School of Business - Executive Education
BioAshley Dudarenok is a Chinese entrepreneur, author, and media personality, recognised by Thinkers50 as a “guru on fast‑evolving trends in China.” She is the founder of ChoZan, an immersive executive education company that helps Fortune 500 leaders learn from China’s digital transformation and innovation ecosystem.
Through China Innovation Tours, executive immersions, and strategic briefings, Ashley and her team provide senior leaders with firsthand access to China’s most innovative companies. ChoZan also delivers proprietary insights, market research, and tailored learning programmes focused on digital transformation, consumer trends, and next‑generation technologies.
Ashley is a sought‑after keynote speaker and the author of several bestselling books on China’s digital economy. She runs a widely read newsletter and engages a B2B community of over 500,000 global China watchers across LinkedIn and YouTube. Her latest venture, The Hidden Switch, spotlights billion‑dollar founders from emerging markets who are reshaping the world. -
Ramzi Emanuel Dudum
Member (Postdoc), Cardiovascular Institute
BioDr. Dudum is a cardiologist and population health expert working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University.
He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.
He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health expert, he leads efforts in the preventive cardiology section related to improving cardiovascular health. -
Beth Duff-Brown
Communications Manager, Health Policy
Current Role at StanfordCommunications Manager for the Center for Health Policy in the Freeman Spogli Institute for International Studies and the Department of Health Policy in the School of Medicine.
-
Mark Duggan
Wayne and Jodi Cooperman Professor and Senior Fellow at the Stanford Institute for Economic Policy Research
BioMark Duggan is a Professor of Economics at Stanford University and a Research Associate at the National Bureau of Economic Research. He received his B.S. and M.S. degrees in Electrical Engineering at M.I.T. in 1992 and 1994, respectively, and his Ph.D. in Economics from Harvard University in 1999. He currently is a Co-Editor at the American Economic Journal: Economic Policy and was previously a Co-Editor at the Journal of Public Economics. Before arriving to Stanford in the summer of 2014, Duggan served on the faculty at the University of Pennsylvania's Wharton School (2011-14), the University of Maryland's Economics Department (2003-11), and the University of Chicago's Economics Department (1999-2003).
Professor Duggan's research focuses primarily on the effect of government expenditure programs such as Social Security, Medicare, and Medicaid on the behavior of individuals and firms. Some of his more recent research is exploring the effect of federal disability programs on the labor market and of changes to the Medicare and Medicaid programs on the cost and quality of health care. He is also estimating the effect of patent reforms in India on the price and utilization of pharmaceutical treatments. His research has been published in leading academic journals including the American Economic Review, the Journal of Political Economy, and the Quarterly Journal of Economics and has been featured in outlets such as The Economist, the New York Times, and the Wall Street Journal.
Professor Duggan was the 2010 recipient of the ASHEcon Medal, which is awarded every two years by the American Society of Health Economists to the economist aged 40 and under in the U.S. who has made the most significant contributions to the field of health economics. Along with his co-author Fiona Scott Morton, he received the National Institute for Health Care Management's 2011 Health Care Research Award for their work on Medicare Part D. He was a Fellow of the Alfred P. Sloan Foundation from 2004 to 2006 and a Visiting Fellow at the Brookings Institution from 2006 to 2007. His research has been funded by the National Science Foundation, the National Institutes of Health, the Social Security Administration, and the Robert Wood Johnson Foundation. Duggan served from 2009 to 2010 as the Senior Economist for Health Care Policy at the White House Council of Economic Advisers and has also been an Expert Witness for the U.S. Department of Justice. -
Rachelle Dugue, MD, PhD
Clinical Assistant Professor, Adult Neurology
BioDr. Dugue is a board-certified neurologist within the Neurohospitalist Division. She cares for patients at both Stanford Health Care and Stanford Health Care Tri-Valley. She received her MD and PhD at SUNY Downstate Medical Center, where she completed a thesis studying novel treatments for traumatic brain injury. Dr. Dugue then completed her neurology residency at Columbia University Medical Center-New York Presbyterian, followed by a vascular neurology fellowship at Stanford University Hospital.
Dr. Dugue provides comprehensive, individualized care for patients with a wide range of neurological conditions. She has been recognized for her dedication to excellence in patient care, medical education, and student mentorship.
Her research interests are centered on acute neurologic care, clinical trials, stroke, and neuroinfectious disease. Dr. Dugue has published in multiple peer-reviewed journals, including The Neurohospitalist, Practical Neurology, Annals of Clinical and Translational Neurology, and Neurology. -
Shefali Dujari, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Dujari is a board-certified neurologist and fellowship-trained neurohospitalist, specializing in the care of acute neurologic disorders. She practices at both Stanford Hospital and Stanford ValleyCare. She completed her medical training at Boston University, internal medicine preliminary year at California Pacific Medical Center, neurology residency at Stanford University, and neurohospitalist fellowship at Stanford University. She serves as the associate program director of the Stanford Adult Neurology Residency program, the Neurosciences Quality Director at ValleyCare, and the Neurology Resident & Fellow Wellness & Mentoring Committee faculty lead. She has a special interest in medical education and quality improvement.
-
Rob Dunbar
W.M. Keck Professor in the School of Earth Sciences, Professor of Oceans, Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Earth System Science
Current Research and Scholarly InterestsOcean processes, biogeochemistry, climatology/paleoclimatology, isotopic chemistry, ocean policy
-
Shawn Dunbar
Motion Graphics Designer, Technical Lead, Teaching and Learning Hub
Current Role at StanfordMotion Graphics Designer & Editor
-
Laramie Duncan
Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsOur work is at the intersection of statistical genetics, psychiatry, and neuroscience. We use massive datasets and primarily computational approaches to identify mechanisms contributing to mental health problems like schizophrenia and depression. The overall goal of the lab is to discover fundamental information about psychiatric disorders, and ultimately to build more effective approaches to classification, prevention, and treatment.
-
Caroline Duncombe
Postdoctoral Scholar, Immunity Transplant Infection
BioDr. Caroline Duncombe is a Postdoctoral Scholar in the Institute for Immunity, Transplantation, and Infection at Stanford University. Her research broadly explores how sex-based differences influence immune responses to infectious diseases. She applies systems-level approaches to investigate molecular and cellular mechanisms underlying immune variation, with the goal of informing more equitable and effective interventions.
Dr. Duncombe earned her PhD in Pathobiology from the University of Washington, where she pursued interdisciplinary research integrating systems biology, immunology, epidemiology, endocrinology, and parasitology. Her work has contributed to a deeper understanding of how sex and sex hormones shape host-pathogen interactions and vaccine responses.
In addition to her academic research, Dr. Duncombe is committed to science communication. She has produced science-focused comedy shows for over four years, using storytelling and humor to make complex scientific ideas more accessible.
Personal Website: carolinethescientist.com
LinkedIn Profile: linkedin.com/in/caroline-duncombe-phd-4ba11a124 -
Eric Dunham
Professor of Geophysics
Current Research and Scholarly InterestsPhysics of natural hazards, specifically earthquakes, tsunamis, and volcanoes. Computational geophysics.
-
Alexander Dunn
Professor of Chemical Engineering
Current Research and Scholarly InterestsMy lab is deeply interested in uncovering the physical principles that underlie the construction of complex, multicellular animal life.
-
Hayley H Dunn
Undergraduate, Symbolic Systems
BioCurrently studying Computer Science and Economics
-
James Dunn
Professor of Surgery (Pediatric Surgery)
Current Research and Scholarly InterestsIntestinal lengthening for short bowel syndrome
Intestinal stem cell therapy for intestinal failure
Skin derived precursor cell therapy for enteric neuromuscular dysfunction
Intestinal tissue engineering -
Jeffrey Dunn, MD
Clinical Professor, Adult Neurology
Current Research and Scholarly InterestsTranslational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.
-
Tamara Dunn
Clinical Associate Professor, Medicine - Hematology
BioDr. Tamara Dunn is a clinical associate professor in the Division of Hematology at the Stanford University School of Medicine. She is a clinician with a special interest in medical education, diversity, equity, and inclusion. Specifically, she is committed to improving workforce diversity and creating inclusive workplaces. She is currently the Program Director for the Stanford Hematology/Oncology Fellowship and one of the Associate Chairs of Diversity and Inclusion for the Department of Medicine at Stanford. She is a member of the inaugural American Society of Hematology (ASH) Ambassador Cohort and serves on the ASH Women in Hematology committee, which she co-chairs. She is on the steering committee and is a mentor for Stanford’s Leadership Education in Advancing Diversity (LEAD) program. She takes pride in treating underserved veterans at the Palo Alto Veterans Hospital, where she sees both classical and malignant hematology. Outside of medicine she enjoys singing, dancing, sports (Go Chiefs! Go Warriors!), board games, movies, and spending time with friends and family including her 3 young children, spouse, and energetic vizsla Casey.
-
Mary Laurence Dunne
Adjunct Professor, Medicine - Primary Care and Population Health
BioDr. Mimi Dunne is a physician leader in palliative and emergency medicine with a longstanding commitment to innovation in end-of-life care and medical education. A 2019-2020 Stanford Distinguished Careers Institute Fellow, Dr. Dunne has co-taught MED 296: Being Mortal at Stanford University School of Medicine.
A graduate of Saint Louis University School of Medicine, she completed postgraduate training at the University of Chicago, certification in Mindfulness-Based Stress Reduction at the University of Massachusetts, and is board-certified in both Emergency Medicine and Hospice and Palliative Medicine. As Medical Director of Hudson Valley Hospice, she founded the region’s first palliative care program in 2001.
Her scholarly work spans emergency medicine, palliative medicine, and global health, and she has authored studies, articles, and book chapters in these fields. She currently serves as an advisor to the African Center for Research in End of Life Care in Rwanda and to Bulamu Health Care in Uganda. -
Mike Dunne
Professor of Photon Science
Current Research and Scholarly InterestsThe Linac Coherent Light Source (LCLS) is the world's first X-Ray Free Electron Laser. It represents a revolution in x-ray science. The x-rays produced by LCLS are a billion times brighter than can be produced by conventional sources, such as a synchrotron, and are delivered in ultrafast bursts- typically a few tens of femtoseconds (10^-15 seconds). This opens up transformational opportunities for the study of structural biology, quantum materials, ultrafast chemistry, and novel states of matter
-
Sebastian Duno-Miranda
Postdoctoral Scholar, Biochemistry
BioI started my training as a biologist at the Universidad Central de Venezuela (UCV) and the Instituto Venezolano de Investigaciones Cientificas (IVIC). My Licentiate thesis degree advisor was Dr. Raúl Padrón, whom with I studied the structure and function of tarantula muscle, a key non-conventional animal model to understand muscle function in humans. Next, I would move to pursue doctoral studies at the University of Vermont, under Dr. David M. Warshaw supervision, studying the molecular mechanics of human cardiac myosin, the motor responsible for powering up the contractions of the human heart, the effect of multiple cardiomyopathy mutations, and the application of machine learning to enhance myosin single-molecule data analysis. Now, I've joined the lab of Dr. James Spudich at Stanford University, to continue pushing the frontiers of knowledge regarding the molecular physiology of human myosins in the context of heart disease. For more details please see https://duno-miranda.org
-
Nikki Duong, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on quality improvement and patient reported outcomes in people with cirrhosis. I also have interests in expanding our breadth of knowledge in caring for patients with gastrointestinal and liver disorders who identify as a sexual and gender minority.
-
Tina Duong MPT, PhD
Senior Research Scientist, Adult Neurology
BioI am a senior research scientist and physical therapist with over 20 years of experience, specializing in neuromuscular clinical research. Currently, I am the Director of clinical outcomes and research developments within the Neuromuscular division and Co-Director, Stanford Innovative Genetic Neurologic Investigation and Treatment Evaluation Center. My doctoral studies focused on understanding the impact of contracture development on subsequent musculoskeletal and biomechanical changes that influence overall functional outcomes. I am deeply committed to advancing my work by creating innovative outcome measures that bridge the gap with traditional metrics for a range of neuromuscular disorders. Furthermore, I am enthusiastic about investigating the therapeutic advantages of incorporating rehabilitation and exercise as complementary treatments for managing neuromuscular conditions.
In my professional pursuits, I prioritize integrity, work ethic, humility, empathy, leadership, initiative, and drive in all my collaborations. Inspired by Ralph Waldo Emerson's poem “"to know even one life has breathed easier because you have lived. This is to have succeeded", I strive to contribute meaningfully in both my personal and professional endeavors. While it can be challenging to articulate one's accomplishments and impact, I aspire to uphold the values and principles that guide me, serving as a compass in navigating both my personal and professional path. I find it difficult to summarize my own accomplishments or impact. So I would like to share a recommendation that was written about me in which I hope to refer back as my north star in both my personal and professional life.
"Dr Tina Duong is a world renown physiotherapist, master trainer, clinical investigator, scientific academician and most importantly an INCREDIBLE person. I had the privilege of working with her side by side during the development of a new therapy for spinal muscular atrophy. Her determination to help the scientific community, patients and carers is truly inspiring. Her knowledge and skills place her at the vanguard of clinical translation of data and meaningful patient outcomes. Her capabilities span everything from publications, meeting moderation, speaker events and clinical training. She has instinctive clinical intuition which allows her to support drug development and translation in both early stage and also during pivotal trial design, data interpretation and patient care and management. Her ethical and moral considerations of medicine and science means she is 100% focused on each individual to support them as best as possible and this is obvious from everyone who has worked or knows her. Her passion, energy and knowledge inspires people, teams and countries! Wherever Tina goes and whatever she embarks on now or in the future, the value she brings is like no one else and her impact is immediate. I personally look forward to the next opportunity to work with Tina as a brilliant scholar. She lives the ambition of: “The world is changed by your example, not by your opinion”
